 |
|
АкушерствоАнатомияАнестезиологияВакцинопрофилактикаВалеологияВетеринарияГигиенаЗаболеванияИммунологияКардиологияНеврологияНефрологияОнкологияОториноларингологияОфтальмологияПаразитологияПедиатрияПервая помощьПсихиатрияПульмонологияРеанимацияРевматологияСтоматологияТерапияТоксикологияТравматологияУрологияФармакологияФармацевтикаФизиотерапияФтизиатрияХирургияЭндокринологияЭпидемиология |
HIV activists protest over drug pricing policy
by Alina Lobzina at 19/07/2012 The Moscow News
Members of patient union Patsientsky Kontrol gathered on Thursday morning outside ViiV’s Moscow office to protest over its pricing policy, saying that in other countries the same treatment costs many times less. “We don’t deny the companies right to gain superprofit from selling their products, but it’s essential to make it possible for people to survive,” said Sergei Golovin, one of the protest organizers. Дата добавления: 2015-02-05 | Просмотры: 675 | Нарушение авторских прав |
Russian HIV activists have accused pharmaceutical companies of cashing on vital medicines, focusing first on ViiV Healthcare, an HIV joint venture of GlaxoSmithKline and Pfizer.